In addition, the mRNA levels of BICC1 were decreased in 18 cancers, such as breast invasive carcinoma, uterine corpus endometrial carcinoma, endocervical adenocarcinoma, and cervical squamous cell carcinoma (Fig. 2A). Here, BICC1 is linked to invasive breast carcinoma.